Abstract
Administration of RU486 to late pregnant rats results in preterm delivery 24 h after treatment and the induction of a luteolytic process after labor. We investigated whether functional changes occurring within the corpora lutea after RU486 treatment were associated with morphologic features of apoptotic cell death. Rats on d 18 of pregnancy were treated with RU486 (5 mg/kg) at 10:00 am and killed 72 h after. We studied the number of apoptotic cells in paraffin sections of the corpora lutea by routine hematoxylin and eosin (H&E) staining, and by in situ 3′ end labeling (TdT-mediated dUTP nick-end labeling [TUNEL]). The corpora lutea were also processed for electron microscopy to study ultrastructural changes after RU486 treatment. The number of cells showing apoptotic nuclei in H&E-stained sections was higher in RU486-treated animals than in controls (vehicle-treated rats). The quantification of the number of apoptotic nuclei within the corpora lutea performed by TUNEL confirmed the higher number of apoptotic nuclei in animals receiving the antigestagen compared with controls. Ultrastructurally, the luteal cells undergoing a poptosis presented a highly deteriorated cytoplasmic organization The nuclei, in an initial step of regression, displayed condensation of the chromatin, a prominent nucleolus, and a perinuclear space. In an advanced step of degeneration, the nuclei showed evidence of large irregular aggregates of condensed chromatin. Prostaglandin F2α(PGF2α), which mediates the luteolytic action of RU486, mimicked the effect of the antigestagen on the induction of apoptosis when administered to rats on d 18 of pregnancy (100 μg at 9:00 am and 1:00 pm), which were killed 72 after the last injection. In conclusion, the present results indicate that functional luteolysis in rats is associated with structural luteal regression with the morphologic features of apoptotic cell death, as demonstrated by studying the luteolytic process induced by the administration of the antigestagen RU486.
Similar content being viewed by others
References
Albarracin, C. T., Parmer, T. G., Duan, W. R., Nelson, S. E., and Gibori, G. (1994). Endocrinology 134, 2453–2460.
Wiest, W. G. and Forbers, T. R. (1964). Endocrinology 74, 149–150.
Bast, J. D. and Melampy, R. M. (1972). Endocrinology 91, 1499–1505.
Telleria, C. M., Stocco, C. O., and Deis, R. P. (1995). J. Steroid Biochem. Mol. Biol. 52, 567–573.
Telleria, C. M., Stocco, C. O., Stati, A. O., Rastrilla, A. M., Carrizo, D. G., Aguado, L. I., and Deis, R. P. (1995). J. Steroid Biochem. Mol. Biol. 55, 385–393.
Philibert, D., Moguilewski, M., Mary, I., Lecaque, D., Tournemine, C., Secchi, J., and Deraedt, R. (1985). In: The antiprogesterone steroid RU486 and human fertility control. Baulieu, E. E. and Segal, S. J. (eds.), Plenum: New York.
Bose, M. J., Germain, G., Nicolle, A., Mouren, M., Philiber, D., and Baulieu, E. E. (1987). J. Reprod. Fertil. 79, 1–8.
Garfield, R. E., Gasc, J. M., and Baulieu, E. E. (1987). Am. J. Obstet. Gynecol. 157, 1281–1285.
Schwartzman, R. A., and Cidlowski, J. A. (1993). Endocr. Rev. 14, 133–151.
Steller, H. (1995). Science 267, 1445–1449.
Vaux, D. L. and Strasser, A. (1996). Proc. Natl. Acad. Sci. USA 93, 2239–2244.
Amsterdam, A., Dantes, A., Selvaraj, N., and Aharoni, D. (1997). Steroids 62, 207–211.
Nicosia, S. V., Diaz, J., Nicosia, R. F., Saunders, B. O., and Muro-Cacho, C. (1995). Ann. Clin. Lab. Sci. 25, 143–157.
Young, F. M., Illingworth, P. J., Lunn, S. F., Harrison, D. J., and Fraser, H. M. (1997). J. Reprod. Fertil. 111, 109–119.
Shikone, T., Yamoto, M., Kokawa, K., Yamashita, K., Nishimori, K., and Nakano, R. (1996). J. Clin. Endocrinol. Metab. 81, 2376–2380.
Juengel, J. L., Garverick, H. A., Johnson, A. L., Youngquist, R. S., and Smith, M. F. (1993). Endocrinology 132, 249–254.
Rueda, B. R., Wegner, J. A., Marion, S. L., Wahlen, D. D., and Hoyer, P. B. (1995). Biol. Reprod. 52, 305–312.
Matsuyama, S., Chang K.-T., Kanuka, H., Ohnishi, M., Ikeda, A., Nishihara, M., and Takahashi, M. (1996). Biol. Reprod. 54, 1245–1251.
Boone, D. L., and Tsang, B. K. (1998). Biol. Reprod. 58, 1533–1539.
Guo, K., Wolf, V., Dharmarajan, A. M., Feng, Z., Bielke, W., Saurer, S., and Friis, R. (1998). Biol. Reprod. 58, 739–746.
Vermouth, N. T., and Deis, R. P. (1975). J. Endocrinol. 66, 21–29.
Cabrol, D., Carbonne, B., Bienkiewicz, A., Dallot, E., Alj, A. E., and Cedard, L. (1991). Prostaglandins 42, 71–79.
Goyeneche, A. A., Telleria, C. M., Gelardi, N. E., and Deis, R. P. (2000). Biol. Reprod. 62(Suppl. 1):214 (abstract 271).
Telleria, C. M., Parmer, T. G., Zhong, L., Clarke, D. L., Albarracin, C. T., Duan, W. R., Linzer D. I. H., and Gibori, G. (1997). Endocrinology 138, 1499–1505.
Aharoni, D., Dantes, A., Oren, M., and Amsterdam, A. (1995). Exp. Cell. Res. 218, 271–282.
Keren-Tal, I., Suh, B.-S., Dantes, A., Lindner, S., Oren, M., and Amsterdam, A. (1995). Exp. Cell. Res. 218, 283–295.
Bussmann, L. E. (1989). J. Reprod. Fertil. 85, 331–341.
Park-Sarge, O.-K., Parmer, T. G., Gu, Y., and Gibori, G. (1995). Endocrinology 136, 1537–1543.
Telleria, C. M., Stocco, C. O., Stati, A. O., and Deis, R. P. (1999). Steroids 64, 760–766.
Behrman, H. R., Endo, T., Aten, R. F., and Musicki, B. (1993). Reprod. Med. Rev. 2, 153–180.
Michael, A. E., Abayasekara, D. R. E., and Webley, G. E. (1994). Mol. Cell. Endocrinol. 99, R1-R9.
Gibori, G. (1993). In: The ovary. Adashi, E. Y. and Leung, P. C. K. (eds.), Raven: New York.
Deis, R. P. (1971). Nature 229, 568.
Okamura, H., Yang, S.-L., Wright, K. H., and Wallach, E. E. (1972). Fertil. Steril. 23, 475–483.
Stocco, C. O., and Deis, R. P. (1996). J. Endocrinol. 150, 423–429.
Singh, G., Singh, M. M., Maitra, S. C., Elger, W., Kalra, V., Upadhyay, S. N., Chowdhury, S. R., and Kamboj, V. P. (1988). J. Reprod. Fertil. 83, 73–83.
Kawano, T., Okamura, H., Tajima, C., Fukuma, K., and Katabuchi, H. (1988). J. Reprod. Fertil. 83, 279–285.
Rotello, R., Lieberman, R., Lepoff, R., and Gerschenson, L. (1992). Am. J. Pathol. 140, 449–456.
Feng, Z., Marti, A., Jehn, B., Altermatt, H. J., Chicaiza, G., and Jaggi, R. (1995). J. Cell. Biol. 131, 1095–1103.
Sugino, N., Telleria, C. M., and Gibori, G. (1997). Endocrinology 138, 4497–4500.
Telleria, C. M., Ou, J., Sugino, N., Ferguson, S., and Gibori, G. (1998). Endocrinology 139, 3597–3605.
Kuranaga, E., Kanuka, H., Hirabayashi, K., Suzuki, M., Nishihara, M., and Takahashi, M. (2000). FEBS Lett. 466, 279–282.
Gaytán, F., Bellido, C., Morales, C., and Sánchez-Criado, J. E. (1998). Biol. Reprod. 59, 1200–1206.
Gibori, G., Khan, I., Warshaw, M. L., McLean, M. P., Puryear, T. K., Nelson, S., Durkee, T. J., Azhar, S., Steinschneider, A., and Rao, M. C. (1988). Recent Prog. Horm. Res. 44, 377–429.
Van der Schepop, H. A. M., de Jong, J. S., van Diest, P. J., and Baak, J. P. A. (1996). J. Clin. Pathol. Mol. Pathol. 49, M214-M217.
Jolly, P. D., Smith, P. R., Heath, D. A., Hudson, N. L., Lun, S., Still, L. A., Watts, C. H., and McNatty, K. P. (1997). Biol. Reprod. 56, 837–846.
Bussmann, L. E., and Deis, R. P. (1979). J. Steroid Biochem. 11, 1485–1489.
Telleria, C. M., Carrizo, D. G., and Deis, R. P. (1994). J. Steroid Biochem. Mol. Biol. 50, 161–166.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Telleria, C.M., Goyeneche, A.A., Cavicchia, J.C. et al. Apoptosis induced by antigestagen RU486 in rat corpus luteum of pregnancy. Endocr 15, 147–155 (2001). https://doi.org/10.1385/ENDO:15:2:147
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/ENDO:15:2:147